Drugs / Dengzhanxixin Capsule
Dengzhanxixin Capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05459519 | Jul 2022 → Dec 2023 | diabetes mellitus, hyperlipidemia, hypertensive disorder | China National Center for Cardiovascular Diseases | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dengzhanxixin Capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05459519 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Dengzhanxixin capsule is an over-the-counter Chinese traditional medicine” NCT05459519 ↗ |